Kolexia
Vincent Julie Gastro-entérologie
Vincent Julie
Gastro-entérologie
Centre Georges-François Leclerc
Dijon, France
71 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Glioblastome Tumeurs du pancréas Métastase tumorale Adénocarcinome Tumeurs du foie Tumeurs du côlon Tumeurs gastro-intestinales Tumeurs de l'estomac

Collaborateurs

Voir plus
Ghiringhelli Francois
Ghiringhelli Francois
Centre Georges-François Leclerc, Dijon, France
Bengrine-Lefevre Leila
Bengrine-Lefevre Leila
Centre Georges-François Leclerc, Dijon, France
Ladoire Sylvain
Ladoire Sylvain
Centre Georges-François Leclerc, Dijon, France
Hennequin Audrey
Hennequin Audrey
Centre Georges-François Leclerc, Dijon, France

Industries

Voir plus
Pierre Fabre
4 collaboration(s)
Dernière en 2021
Servier
3 collaboration(s)
Dernière en 2022
Amgen
2 collaboration(s)
Dernière en 2021
Novartis
1 collaboration(s)
Dernière en 2020

Dernières activités

Voir plus
StrateGlio: Phase III Randomised Trial Evaluating Treatment Intensification With Temozolomide in Adults With a Glioblastoma
Essai Clinique (Centre Oscar-Lambret)   08 février 2024
FOLFIRI-bevacizumab as a second-line treatment for advanced biliary tract cancer after gemcitabine-based chemotherapy.
Frontiers in oncology   30 novembre 2023
SO-8 Predictive values of blood-based RNA signature for the FOLFIRINOX/FOLFOX response in advanced pancreatic cancer
Abstract Book of the ESMO 25th World Congress on Gastrointestinal Cancer 2023, Barcelona, Spain, 28 June - 1 July 2023   01 juin 2023
Performance of a blood-based RNA signature for gemcitabine-based treatment in metastatic pancreatic adenocarcinoma.
Journal of gastrointestinal oncology   10 avril 2023
Efficacy of Chemotherapy Plus Bevacizumab in Recurrent Glioblastoma Multiform: A Real-life Study.
Anticancer research   05 décembre 2022
Partial splenic embolization with Glubran 2/Lipiodol mixture for oncological patients with hypersplenism-related thrombocytopenia requiring systemic chemotherapy.
Quantitative imaging in medicine and surgery   08 avril 2022
Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional study.
European journal of cancer (Oxford, England : 1990)   01 février 2022
Phase I Dose-Escalation Trial of an Innovative Chemotherapy Regimen Combining a Fractionated Dose of Irinotecan Plus Bevacizumab, Oxaliplatin, 5-Fluorouracil, and Folinic Acid (bFOLFIRINOX-3) in Chemorefractory Metastatic Colorectal Cancer.
Cancers   30 octobre 2021
361P Efficacy of chemotherapy plus bevacizumab in recurrent multiforme glioblastoma: A real-life study
Abstract Book of the ESMO Congress 2021, 16 – 21 September 2021   01 septembre 2021
Seroprevalence of SARS-CoV-2 among the staff and patients of a French cancer centre after first lockdown: The canSEROcov study.
European journal of cancer (Oxford, England : 1990)   27 février 2021